President-elect Donald Trump‘s transition team is planning to eliminate a $7,500 electric vehicle tax credit that helps ...

Bivamelagon is under clinical development by Rhythm Pharmaceuticals and currently in Phase II for Obesity. According to GlobalData, Phase II drugs for Obesity have a 29% phase transition success rate ...

MET-3 is under clinical development by Nubiyota and currently in Phase II for Hypertriglyceridemia. According to GlobalData, Phase II drugs for Hypertriglyceridemia have a 52% phase transition success ...

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

Even before Trump enters the White House, the planet is showing worrying vital signs with scientists virtually certain 2024 ...